SCHEMBL4513559

SCHEMBL4513559

CSc1ccc(C2CCN(CCC3CCN(C(=O)OC(C)(C)C)CC3)CC2)cc1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 8/20 0.70
NAMPT P43490 1/20 0.51
CHRM4 P08173 1/20 0.44
KDM4E B2RXH2 2/20 0.44
PKM P14618 1/20 0.44
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
CCR2 P41597 1/20 0.43
JAK2 O60674 1/20 0.43
JAK3 P52333 1/20 0.43
PTK2 Q05397 1/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
THRB P10828 1/20 0.42
PTPN2 P17706 1/20 0.42
PTPN1 P18031 1/20 0.42
PTPN6 P29350 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4514511 0.89 GPR119 (0.73) GPR119NAMPTKDM4EDDB1CRBN
SCHEMBL4510819 0.84 GPR119 (0.71) GPR119
SCHEMBL4513442 0.82 GPR119 (0.55) GPR119CHRM4KDM4EPKM
SCHEMBL12965453 0.82 GPR119 (1.00) GPR119NAMPTKDM4EPKM
SCHEMBL12965145 0.82 GPR119 (1.00) GPR119NAMPTKDM4EPKM
SCHEMBL15412755 0.82 GPR119 (1.00) GPR119NAMPTKDM4EPKM
SCHEMBL31127612 0.81 CRBN (0.57) GPR119NAMPTKDM4EDDB1CRBN
SCHEMBL7364019 0.81 GPR119 (0.49) GPR119NAMPTCHRM4KDM4EPKM
SCHEMBL6011556 0.80 GPR119 (0.62) GPR119KDM4EPKMMAPTTHRB
SCHEMBL4502678 0.80 GPR119 (0.60) GPR119KDM4EPKMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203676-A1 G-protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2009-08-13 US disclosed
US-20090203676-A1 G-protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2009-08-13 US disclosed
US-20090203676-A1 G-protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2009-08-13 US disclosed
CN-101252929-A G protein-coupled receptor agonists PROSIDION LTD (GB) 2008-08-27 CN disclosed
EP-1909791-A1 G-PROTEIN COUPLED RECEPTOR AGONISTS Prosidion Limited (GB) 2008-04-16 EP disclosed
WO-2007003964-A1 G-PROTEIN COUPLED RECEPTOR AGONISTS PROSIDION LIMITED (GB) 2007-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203676-A1 G-protein Coupled Receptor Agonists GPR119, GCGR, GPBAR1 GPR119 1/4885NAMPT 3068/4885CHRM4 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.